Rituximab, gemcitabine, cisplatin, and methylprednisolone (R-GEM-P) in treatment of relapsed diffuse large B-cell lymphoma (DLBCL).
Sarah Rachel Barton
No relevant relationships to disclose
Eliza Anne Hawkes
Other Remuneration - Roche
David Cunningham
Consultant or Advisory Role - Amgen (U); Roche (U)
Research Funding - Amgen; Celgene; Merck Serono; Novartis; Roche; Sanofi
Clare Peckitt
No relevant relationships to disclose
Sue Chua
No relevant relationships to disclose
Andrew Wotherspoon
No relevant relationships to disclose
Ayoma Attygalle
No relevant relationships to disclose
Alan Horwich
No relevant relationships to disclose
Claire E. Dearden
Consultant or Advisory Role - Roche
Honoraria - Roche
Mike Potter
No relevant relationships to disclose
Ian Chau
No relevant relationships to disclose